Daryl Boffard, MD
Gynecology · Union, NJNPI 1497763874
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $47,882 of the $55,224 with a category attached, or 86.7%. 29 manufacturers reported payments, led by Organon at 56.9% of the total. Reporting peaked in 2021 at $15,716 and has fallen 76.7% since, to $3,659 in 2025. Among gynecology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 463 payments — averaging $119.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$31K
- Duchesnay USA Incorporated$6K
- Coopersurgical, Inc.$5K
- Merck$5K
- Exeltis, USA Inc.$2K
- Myovant Sciences Inc.$2K
- plus $4K from 23 others
What the payments were for
- Consulting fees$1,3602%
- Speaking & faculty fees$47,88287%
- Travel & lodging$4181%
- Food & beverage$5,32310%
- Education$2410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 67 | $31,433 |
| Duchesnay USA Incorporated | 17 | $6,269 |
| Coopersurgical, Inc. | 8 | $4,905 |
| Merck | 8 | $4,899 |
| Exeltis, USA Inc. | 163 | $1,691 |
| Myovant Sciences Inc. | 3 | $1,632 |
| Johnson & Johnson | 3 | $1,451 |
| Mayne Pharma Commercial LLC | 25 | $435 |
| Avion Pharmaceuticals | 49 | $357 |
| Astellas Pharma US Inc | 13 | $341 |
| AbbVie(2 entities) | 23 | $320 |
| Therapeuticsmd, Inc. | 20 | $224 |
| Sumitomo Pharma America, Inc. | 7 | $201 |
| Millicent US Inc | 12 | $165 |
| Scynexis, Inc. | 18 | $161 |
| Gynesonics, Inc. | 1 | $148 |
| Hologic Sales And Service, LLC | 2 | $108 |
| Novo Nordisk | 1 | $108 |
| Dysis Medical, Inc. | 2 | $76 |
| Evofem Biosciences, Inc. | 5 | $70 |
| Vertical Pharmaceuticals, LLC | 3 | $55 |
| Agile Therapeutics, Inc. | 3 | $43 |
| Lupin Inc. | 3 | $39 |
| Meditrina | 2 | $34 |
| Aspira Women's Health Inc | 1 | $17 |
| AMAG Pharmaceuticals, Inc. | 1 | $17 |
| Pfizer | 1 | $14 |
| Gilead | 1 | $11 |
| Alydia Health | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$35,355
- Osphena$6,137
- Paragard$4,879
- DERMABOND Portfolio$1,360
- MONOCRYL$1,360
- VICRYL$1,360
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM$148
- MYFEMBREE$120
- Wegovy$108
How this compares
$55,224 in reported general payments places this provider in the 90th percentile of 97 gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 16 | $682 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Union
- Angela BuontempoUnion$292
- James TursiLumberton$217K
- Marco PelosiBayonne$164K
- Heather van RaaltePrinceton$140K
- Scott EderPrinceton$124K
- Michael VardyEnglewood$114K
- Shyama MathewsPlainsboro$54K
- Lora LiuJersey City$36K
- Mark EinsteinNewark$27K
- Jessica Opoku-AnaneNew Brunswick$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.